Robert-jan T. Palstra

Rotterdam, ZH 3015GD, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes.

Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes.

Journal: Viruses

Published: December 05, 2025

Targeting HIV-1 transcription: road to a cure?

Targeting HIV-1 transcription: road to a cure?

Journal: Transcription

Published: November 14, 2025

Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal.

Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal.

Journal: Journal of virus eradication

Published: October 24, 2024

Integrative analysis of patient-derived tumoroids and ex vivo organoid modelling of ARID1A loss in bladder cancer reveals therapeutic molecular targets.

Integrative analysis of patient-derived tumoroids and ex vivo organoid modelling of ARID1A loss in bladder cancer reveals therapeutic molecular targets.

Journal: Cancer letters

Published: August 19, 2024

PCID2 dysregulates transcription and viral RNA processing to promote HIV-1 latency.

PCID2 dysregulates transcription and viral RNA processing to promote HIV-1 latency.

Journal: iScience

Published: September 07, 2023

Specific quantification of inducible HIV-1 reservoir by RT-LAMP.

Specific quantification of inducible HIV-1 reservoir by RT-LAMP.

Journal: Communications medicine

Published: July 26, 2023

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.

Journal: Science advances

Published: March 15, 2023

A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.

A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.

Journal: mBio

Published: December 07, 2021

Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents.

Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents.

Journal: Nucleic acids research

Published: December 03, 2021

Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir.

Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir.

Journal: Nature communications

Published: October 09, 2020

Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.

Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.

Journal: eLife

Published: August 25, 2020

Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.

Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.

Journal: Science advances

Published: December 20, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026